Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlaxoSmithKline PLC

41.20
+0.05000.12%
Post-market: 40.75-0.4500-1.09%17:23 EDT
Volume:3.23M
Turnover:132.83M
Market Cap:83.49B
PE:20.95
High:41.33
Open:41.04
Low:40.96
Close:41.15
Loading ...

GSK Gets FDA Approval for Mepolizumab Use in Adult COPD Patients

MT Newswires Live
·
23 May

GSK reports Nucala approved by FDA for adults with COPD

TIPRANKS
·
23 May

Press Release: AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition

Dow Jones
·
22 May

GSK Advances Share Buyback Program with Recent Purchase

TIPRANKS
·
22 May

GSK Climbs Wednesday, Outperforms Market

Dow Jones
·
22 May

Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
21 May

Vaccine Stocks Surge with Moderna up 11%

Tiger Newspress
·
20 May

GSK Executives Acquire ADSs Through Dividend Reinvestment

TIPRANKS
·
20 May

GSK Enhances Shareholder Value with Strategic Share Buyback

TIPRANKS
·
20 May

GSK Says Blenrep Combinations Approved in Japan for Relapsed, Refractory Multiple Myeloma

MT Newswires Live
·
19 May

GSK Advances Friday, Outperforms Market

Dow Jones
·
17 May

Top Midday Stories: Qatar Orders 160 Boeing Jets for Over $200 Billion; Super Micro, DataVolt Form $20 Billion Partnership

MT Newswires Live
·
14 May

Sector Update: Health Care Stocks Rise Premarket Wednesday

MT Newswires Live
·
14 May

J.P. Morgan Remains a Sell on GlaxoSmithKline (GSK)

TIPRANKS
·
14 May

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid US-China Tariff Pause, Softer Inflation Data

MT Newswires Live
·
14 May

GSK to Acquire Liver Disease Treatment From Boston Pharmaceuticals for up to $2 Billion

MT Newswires Live
·
14 May

Press Release: GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

Dow Jones
·
14 May

GSK Slips Tuesday, Underperforms Market

Dow Jones
·
14 May

GSK Executives Acquire Shares Under Reward Plan

TIPRANKS
·
13 May

GSK, iTeos Therapeutics End Belrestotug Development Program

MT Newswires Live
·
13 May